- Home
- ARBB vs QUCY Comparison
ARBB vs QUCY Comparison
Compare ARBB & QUCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARBB | QUCY |
|---|---|---|
| Founded | 1997 | 2008 |
| Country | Singapore | Germany |
| Employees | N/A | 13 |
| Industry | EDP Services | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.9M | 5.9M |
| IPO Year | 2022 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ARBB | QUCY |
|---|---|---|
| Price | $4.69 | $3.41 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $20.00 | N/A |
| AVG Volume (30 Days) | 23.2K | ★ 30.0M |
| Earning Date | 05-12-2026 | 06-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $74.34 |
| Revenue Next Year | $24.79 | $171.48 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.46 | $0.30 |
| 52 Week High | $13.89 | $3.97 |
Technical Indicators
Market Signals| Indicator | ARBB | QUCY |
|---|---|---|
| Relative Strength Index (RSI) | 50.47 | 93.25 |
| Support Level | $3.86 | $0.39 |
| Resistance Level | $5.27 | N/A |
| Average True Range (ATR) | 0.48 | 0.46 |
| MACD | -0.01 | 0.30 |
| Stochastic Oscillator | 29.39 | 67.06 |
Price Performance
Historical ComparisonAbout ARBB ARB IOT Group Limited
ARB IOT Group Ltd is a provider of complete solutions to the clients for the integration of Internet of Things (IoT) systems and devices from designing to project deployment. The company offers a wide range of IoT systems as well as provides customers with a substantial range of services such as system integration and system support services. It delivers solutions like designing, installation, testing and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company operates in two reportable segments: (i) the provision of hardware and software of IoT solutions and (ii) Investment holding and others. The majority of revenue is generated from the IoT solutions segment.
About QUCY Mainz Biomed N.V. Ordinary Shares
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.